Argentus Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-3,086
Closed -$515K 13
2016
Q3
$515K Sell
3,086
-463
-13% -$78.3K 0.18% 141
2016
Q2
$540K Sell
3,549
-772
-18% -$120K 0.23% 115
2016
Q1
$652K Sell
4,321
-757
-15% -$112K 0.23% 125
2015
Q4
$824K Sell
5,078
-24,580
-83% -$3.86M 0.26% 99
2015
Q3
$4.1M Buy
29,658
+14,522
+96% +$2.29M 0.61% 39
2015
Q2
$2.32M Buy
15,136
+5
+0% +$801 0.35% 75
2015
Q1
$2.42M Buy
15,131
+5,982
+65% +$942K 0.38% 72
2014
Q4
$1.46M Buy
9,149
+315
+4% +$49.1K 0.24% 120
2014
Q3
$1.24M Buy
+8,834
New +$1.15M 0.2% 146

Other funds holding AMGN

Argentus Capital Management's AMGN Position: Q4 2016 in Review

Argentus Capital Management sold out of Amgen (AMGN) in Q4 2016, closing a stake of 3,086 shares — an estimated $515K sold.

Argentus Capital Management first reported a position in AMGN in Q3 2014 and held it in 9 quarters. The position peaked at $4.1M in Q3 2015. 1,541 funds tracked by Wall St. Rank hold AMGN as of Q4 2016.

  • Argentus Capital Management reported no remaining Amgen position as of Q4 2016 after selling out during the quarter.
  • Argentus Capital Management sold 3,086 Amgen shares in Q4 2016, an estimated $515K.
  • Argentus Capital Management first reported a position in Amgen in Q3 2014 and held it in 9 quarters.
  • Argentus Capital Management's Amgen position peaked at $4.1M in Q3 2015.
  • 1,541 funds tracked by Wall St. Rank held Amgen as of Q4 2016.

Based on Argentus Capital Management's 13F filing for Q4 2016.